Resultado da Busca
Há 1 dia · Keytruda ist neu zugelassen in Kombination mit Fluoropyrimidin- und platinhaltiger Chemotherapie zur Erstlinienbehandlung des lokal fortgeschrittenen, nicht resezierbaren oder metastasierten HER2-negativen Adenokarzinoms des Magens oder des gastroösophagealen Überganges bei Erwachsenen, deren Tumore PD-L1 mit einem CPS ≥1 exprimieren ...
Há 17 horas · In a decision that issued last week, a Patent Trial and Appeal Board ("PTAB") panel instituted inter partes review ("IPR") of a petition filed by Merck Sharp & Dohme LLC ("Merck") for a patent owned by The Johns Hopkins University ("Johns Hopkins"), U.S. Patent No. 11,591,393 (the '393 patent). The '393 patent issued on February 28, 2023, and ...
Há 5 dias · Merck Sharp & Dohme (Sweden) Aktiebolag har en tillväxt på 6.4 % jämfört med föregående år. Vinstmarginalen för Merck Sharp & Dohme (Sweden) Aktiebolag ligger på 3.7 % och placerar bolaget på plats 299,583 i Sverige av 748,693 aktiebolag och i kommunen på plats 57,186 av 162,164 aktiebolag.
Há 5 dias · Merck Sharp & Dohme discloses new adenosine A2A and A2B receptor antagonists. June 27, 2024. A Merck Sharp & Dohme LLC patent details new adenosine A2A and/or A2B receptor antagonists potentially useful for the treatment of cancer. BioWorld Science Cancer Patents.
Há 2 dias · L'entreprise LABORATOIRES MERCK SHARP & DOHME-CHIBRET a été immatriculée en tout début d'année 1979, il y a 43 ans. Cette SAS dispose d'un capital social de 21 520 000 €. À notre connaissance, LABORATOIRES MERCK SHARP & DOHME-CHIBRET est présente sur Internet : elle anime une page Facebook, un compte Twitter et une page LinkedIn et dispose d'un site Internet pour se faire connaître ...
Há 5 dias · MK-0472，由Merck Sharp & Dohme LLC公司最早进行研发，目前全球最高研发状态为临床1期，治疗领域: 肿瘤，在研适应症: 晚期恶性实体瘤,转移性实体瘤，在研机构: Merck Sharp & Dohme LLC。
Há 2 dias · Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company.
